Clinical Trial

Role of Tryptase Levels in Patients With Stable Coronary Artery Disease.

Study acronym: TRY-CAD
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 28, 2025 (before its estimated January 11, 2026 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to measure the levels of serum tryptase and correlate them with the severity of coronary artery disease in study population. In addition, it will evaluate the usability of tryptase levels as a prognostic biomarker for future cardiovascular events.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-02; most recent amendment 2025-05-26.
Trial Details
NCT Number NCT06958016
Lead Sponsor University of Thessaly
Conditions Chronic Coronary Syndrome
Enrollment 200 participants
Start Date 2024-01-12
Primary Completion 2026-01-11 (estimated)
Study Completion 2027-01-11 (estimated)
Updated on ClinicalTrials.gov 2025-05-28